Ghosh, S., Zheng, M., He, J., Wu, Y., Zhang, Y., Wang, W., Shen, J., Yeung, K.W., Neelakantan, P., Xu, C. and Qiao, W., 2024. Electrically-driven drug delivery into deep cutaneous tissue by conductive microneedles for fungal infection eradication and protective immunity. Biomaterials, p.122908.
Abstract: Fungal infections affect over 13 million people worldwide and are responsible for 1.5 million deaths annually. Some deep cutaneous fungal infections may extend the dermal barriers to cause systemic infection, resulting in substantial morbidity and mortality. However, the management of deep cutaneous fungal infection is challenging and yet overlooked by traditional treatments, which only offer limited drug availability within deep tissue. In this study, we have developed an electrically stimulated microneedle patch to deliver miconazole into the subcutaneous layer. We tested its antifungal efficacy using in vitro and ex vivo models that mimic fungal infection. Moreover, we confirmed its anti-fungal and wound-healing effects in a murine subcutaneous fungal infection model. Furthermore, our findings also showed that the combination of miconazole and applied current synergistically stimulated the nociceptive sensory nerves, thereby activating protective cutaneous immunity mediated by dermal dendritic and γδ-T cells. Collectively, this study provides a new strategy for minimally invasive delivery of therapeutic agents and the modulation of the neuro-immune axis in deep tissue.
Ghosh S, Kulkarni S, More N, Singh NK, Velyutham R, Kumar NR, Kapusetti G. Cellulose-based bioabsorbable and antibiotic coated surgical staple with bioinspired design for efficient wound closure. International Journal of Biological Macromolecules. 2023, 26:126477. https://doi.org/10.1016/j.ijbiomac.2023.126477
Abstract: The quest to design a flawless wound closure system began long ago and is still underway. Introducing surgical staples is one of the most significant breakthroughs in this effort. In this work, we developed a biodegradable surgical staple to meet the optimal wound closure system criteria and other clinical requirements, such as radiography compatibility and secondary infection prevention. To meet these requirements, a naturally derived cellulose acetate (CA) fiber-reinforced poly-(l-lactic acid) (PLLA) composite was synthesized, and its physicochemical properties were determined using several characterizations such as Fourier-transform infrared spectroscopy (FTIR), Differential scanning calorimetry (DSC) and Universal testing machine (UTM), etc. Taking cues from the Mantis's foreleg, a novel staple design was implemented and verified using Finite Element Analysis (FEA). The CA + PLLA staples were fabricated using melt-casted/3D-printing processes. The staples exhibited excellent biodegradation in both wound and physiological microenvironments with sufficient puncturing strength and later closed the wound's edges mechanically. In addition, the CA + PLLA staples also exhibit metal-like ductility properties to withstand horizontal skin tensions during the healing process. Further, the staples are coated with an antibiotic to combat infections effectively to provide better healing.
Shah, D.K.#, Ghosh, S.#, More, N. et al. ECM-mimetic, NSAIDs loaded thermo-responsive, immunomodulatory hydrogel for rheumatoid arthritis treatment. BMC Biotechnol 24, 26 (2024). https://doi.org/10.1186/s12896-024-00856-3
Abstract:
Background: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and it leads to irreversible
inflammation in intra-articular joints. Current treatment approaches for RA include non-steroidal anti-inflammatory
drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), corticosteroids, and biological agents. To
overcome the drug-associated toxicity of conventional therapy and transdermal tissue barrier, an injectable NSAID-
loaded hydrogel system was developed and explored its efficacy.
Results: The surface morphology and porosity of the hydrogels indicate that they mimic the natural ECM, which is
greatly beneficial for tissue healing. Further, NSAIDs, i.e., diclofenac sodium, were loaded into the hydrogel, and the in vitro drug release pattern was found to be burst release for 24 h and subsequently sustainable release of 50% drug up to 10 days. The DPPH assay revealed that the hydrogels have good radical scavenging activity. The biocompatibility study carried out by MTT assay proved good biocompatibility and anti-inflammatory activity of the hydrogels was carried out by gene expression study in RAW 264.7 cells, which indicate the downregulation of several key inflammatory genes such as COX-2, TNF-α & 18s.
Conclusion: In summary, the proposed ECM-mimetic, thermo-sensitive in situ hydrogels may be utilized for intra-
articular inflammation modulation and can be beneficial by reducing the frequency of medication and providing
optimum lubrication at intra-articular joints.
Ghosh S, Vaidya S, More N, Kapusetti G. Piezoelectric-based Bioactive Zinc Oxide-Cellulose Acetate Electrospun Mats for Efficient Wound Healing: An In Vitro Insights. Frontiers in Immunology, 14:2023, 1245343. doi: 10.3389/fimmu.2023.1245343
Abstract: Being a complex physiological process involving the removal of damaged tissue debris and creating a new microenvironment for host tissue regeneration, wound healing is still a major challenge for healthcare professionals. Disruption of this process can lead to tissue inflammation, pathogenic infections, and scar formation. Current wound healing treatments primarily focus on passive tissue healing, lacking active engagement in the healing process. In recent years, a new class of functional biomaterials based on piezoelectric properties has emerged, which can actively participate in the wound healing process by harnessing mechanical forces generated from body movement. Herein, we have fabricated a bioactive Cellulose Acetate (CA) electrospun nanofibrous mat incorporating zinc oxide (ZnO) and investigated its efficiency for accelerated wound healing. We have characterized the physicochemical properties of the fabricated nanofibrous mats using various assays, including SEM, FTIR, TGA, mechanical testing, degradation analysis, porosity measurement, hemolysis assay, and piezoelectric d33 coefficient measurement. Through our investigation, we discovered the tunned piezoelectric coefficient of fabricated specimens due to incorporating ZnO into the CA fibers. In vitro studies also confirmed enhanced cell adhesion, proliferation, and migration, indicating faster wound healing potential. Overall, our findings support the efficacy of piezoelectric-based ZnO-incorporated bioactive CA nanofibrous mats for efficient wound healing.
G. H. Gupta, K. Mohan, S. Ghosh, Srivalliputtur Sarath babu, Ravichandiran Velyutham, Govinda Kapusetti,
Label-Free detection of Poly-Cystic ovarian syndrome using a highly conductive 2-D rGO/MoS2/PANI nanocomposite based immunosensor,
Bioelectrochemistry, 2024, 108681, ISSN 1567-5394, https://doi.org/10.1016/j.bioelechem.2024.108681 (https://www.sciencedirect.com/science/article/pii/S1567539424000434)
Abstract: Polycystic ovarian syndrome (PCOS) is an endocrinal disorder characterized by multiple tiny cysts, amenorrhea, dysmenorrhea, hirsutism, and infertility. The current diagnostic tools comprise of expensive, time-consuming ultrasonography to serological test, which have low patient compliance. To address these limitations, we have developed a highly sensitive, cost effective and ultrafast immunosensor for the diagnosis of PCOS. Herein, we have fabricated a 2-D electro conductive composites of reduced Graphene oxide (rGO), Molybdenum disulfide (MoS2), and Polyaniline (PANI) as electrode material. Furthermore, for detecting an early and non-cyclic biomarker of PCOS, i.e. anti-Mullerian hormone (AMH). We utilize the specific antigen–antibody mechanism, in which monoclonal Anti-AMH antibodies were covalently immobilized using EDC-NHS chemistry on electrode. The developed biosensor was Physicochemical and electrochemically characterized to demonstrate its efficiency. Further we have investigated the biosensor’s performance with Cyclic Voltammetry, Differential Pulse Voltammetry, and Electrochemical Impedance Spectroscopy. We have validated that under the optimized condition the immunosensor exhibits higher sensitivity with a LOD of ∼ 2.0 ng/mL with a linear range up to 100 ng/mL. Furthermore, this immunosensor works efficiently with a lower sample volume (>5 μL), which provides a sensitive, reproducible, low-cost, rapid analysis to detect AMH level in PCOS diagnosis.
Choppadandi M, Soumya K, Ghosh S, Balu A, Shingote T, Babu SS, Prasanna VS, Arumugam S, Velyutham R, Yallapu MM, Kapusetti G. Dual Functional Magnetic Nanoparticles Conjugated with Carbon Quantum Dots for Hyperthermia and Photodynamic Therapy for Cancer. Nanotheranostics 2024; 8(4):442-457. doi:10.7150/ntno.91871. https://www.ntno.org/v08p0442.htm
Abstract: The global incidence of cancer continues to rise, posing a significant public health concern. Although numerous cancer therapies exist, each has limitations and complications. The present study explores alternative cancer treatment approaches, combining hyperthermia and photodynamic therapy (PDT). Magnetic nanoparticles (MNPs) and amine-functionalized carbon quantum dots (A-CQDs) were synthesized separately and then covalently conjugated to form a single nanosystem for combinational therapy (M-CQDs). The successful conjugation was confirmed using zeta potential, Fourier transform infrared spectroscopy (FT-IR), and UV-visible spectroscopy. Morphological examination in transmission electron microscopy (TEM) further verified the conjugation of CQDs with MNPs. Energy dispersive X-ray spectroscopy (EDX) revealed that M-CQDs contain approximately 12 weight percentages of carbon. Hyperthermia studies showed that both MNP and M-CQDs maintain a constant therapeutic temperature at lower frequencies (260.84 kHz) with high specific absorption rates (SAR) of 118.11 and 95.04 W/g, respectively. In vitro studies demonstrated that MNPs, A-CQDs, and M-CQDs are non-toxic, and combinational therapy (PDT + hyperthermia) resulted in significantly lower cell viability (~4%) compared to individual therapies. Similar results were obtained with Hoechst and propidium iodide (PI) staining assays. Hence, the combination therapy of PDT and hyperthermia shows promise as a potential alternative to conventional therapies, and it could be further explored in combination with existing conventional treatments.
Jailani, A.; Kalimuthu, S.; Rajasekar, V.; Ghosh, S.; Collart-Dutilleul, P.-Y.; Fatima, N.; Koo, H.; Solomon, A.P.; Cuisinier, F.; Neelakantan, P. Trans-Cinnamaldehyde Eluting Porous Silicon Microparticles Mitigate Cariogenic Biofilms. Pharmaceutics 2022, 14, 1428. https://doi.org/10.3390/pharmaceutics14071428
Abstract: Dental caries, a preventable disease, is caused by highly-adherent, acid-producing biofilms composed of bacteria and yeasts. Current caries-preventive approaches are ineffective in controlling biofilm development. Recent studies demonstrate definite advantages in using natural compounds such as trans-cinnamaldehyde in thwarting biofilm assembly, and yet, the remarkable difficulty in delivering such hydrophobic bioactive molecules prevents further development. To address this critical challenge, we have developed an innovative platform composed of components with a proven track record of safety. We fabricated and thoroughly characterised porous silicon (pSi) microparticles to carry and deliver the natural phenyl propanoid trans-cinnamaldehyde (TC). We investigated its effects on preventing the development of cross-kingdom biofilms (Streptococcus mutans and Candida albicans), typical of dental caries found in children. The prepared pSi microparticles were roughly cubic in structure with 70–75% porosity, to which the TC (pSi-TC) was loaded with about 45% efficiency. The pSi-TC particles exhibited a controlled release of the cargo over a 14-day period. Notably, pSi-TC significantly inhibited biofilms, specifically downregulating the glucan synthesis pathways, leading to reduced adhesion to the substrate. Acid production, a vital virulent trait for caries development, was also hindered by pSi-TC. This pioneering study highlights the potential to develop the novel pSi-TC as a dental caries-preventive material.
Electroconductive Microneedle for Drug Delivery into Deep Tissue
US Provisional Patent No.- 63/621,121
Link: https://scholars.cityu.edu.hk/en/publications/electroconductive-microneedle-for-drug-delivery-into-deep-tissue(bd792428-d0a6-4cfd-9518-680bf1727f0b).html
Bio-absorbable and Antibiotic Coated Surgical Staples for Wound Closing
Indian Patent No.- 202321036501
Publication No.- 26/2023
Link: https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails
Ganguly A, Babu SS, Ghosh S, Velyutham R, Kapusetti G. Advances and Future Trends in the Detection of Beta-Amyloid: A Comprehensive Review. Medical Engineering & Physics. 2024 Dec 2:104269. https://doi.org/10.1016/j.medengphy.2024.104269
Abstract: The neurodegenerative condition known as Alzheimer's disease is typified by the build-up of beta-amyloid plaques within the brain. The timely and precise identification of beta-amyloid is essential for understanding disease progression and developing effective therapeutic interventions. This comprehensive review explores the diverse landscape of beta-amyloid detection methods, ranging from traditional immunoassays to cutting-edge technologies. The review critically examines the strengths and limitations of established techniques such as ELISA, PET, and MRI, providing insights into their roles in research and clinical settings. Emerging technologies, including electrochemical methods, nanotechnology, fluorescence techniques, point-of-care devices, and machine learning integration, are thoroughly discussed, emphasizing recent breakthroughs and their potential for revolutionizing beta-amyloid detection. Furthermore, the review delves into the challenges associated with current detection methods, such as sensitivity, specificity, and accessibility. By amalgamating knowledge from multidisciplinary approaches, this review aims to guide researchers, clinicians, and policymakers in navigating the complex landscape of beta-amyloid detection, ultimately contributing to advancements in Alzheimer's disease diagnostics and therapeutics.
Ghosh S, Qiao W, Yang Z, Orrego S, Neelakantan P. Engineering Dental Tissues Using Biomaterials with Piezoelectric Effect: Current Progress and Future Perspectives. Journal of Functional Biomaterials. 2023; 14(1):8. https://doi.org/10.3390/jfb14010008
Abstract: Dental caries, a preventable disease, is caused by highly-adherent, acid-producing biofilms composed of bacteria and yeasts. Current caries-preventive approaches are ineffective in controlling biofilm development. Recent studies demonstrate definite advantages in using natural compounds such as trans-cinnamaldehyde in thwarting biofilm assembly, and yet, the remarkable difficulty in delivering such hydrophobic bioactive molecules prevents further development. To address this critical challenge, we have developed an innovative platform composed of components with a proven track record of safety. We fabricated and thoroughly characterised porous silicon (pSi) microparticles to carry and deliver the natural phenyl propanoid trans-cinnamaldehyde (TC). We investigated its effects on preventing the development of cross-kingdom biofilms (Streptococcus mutans and Candida albicans), typical of dental caries found in children. The prepared pSi microparticles were roughly cubic in structure with 70–75% porosity, to which the TC (pSi-TC) was loaded with about 45% efficiency. The pSi-TC particles exhibited a controlled release of the cargo over a 14-day period. Notably, pSi-TC significantly inhibited biofilms, specifically downregulating the glucan synthesis pathways, leading to reduced adhesion to the substrate. Acid production, a vital virulent trait for caries development, was also hindered by pSi-TC. This pioneering study highlights the potential to develop the novel pSi-TC as a dental caries-preventive material.
Ghosh, S., More, N., & Kapusetti, G. (2022). Surgical staples: Current state-of-the-art and future prospective. Medicine in Novel Technology and Devices, 100166. https://doi.org/10.1016/j.medntd.2022.100166
Abstract: Wound closing is one of the widely performed and prominent clinical practices in the surgical intervention process. A physician or surgeon has several options ranging from surgical sutures and adhesive strips to fibrin glue for effective wound closure to close the commonly occurring surgical cuts and deep skin tissue injuries. However, all the commercially available wound closure devices have some limitations in each and another perspective. From the beginning of the late 90s, surgical staples got tremendous attention as efficient wound closure devices for their time-effective and sufficient mechanical strength, performance feasibility, fewer chances of surgical site infection and require minimal expertise characteristics in consideration of remote location. Even in the context of the recent COVID19 pandemic, the clinical acceptance and patient compliance for the staples have increased due to minimizing the chances of prolonged interaction between the patient and physicians. The surgical staples application is extensive and diversified, ranging from common external cuts to highly complex surgery procedures like laparoscopic appendectomy, intestinal anastomosis, etc. Thus, in this literature review, we try to give a comprehensive glimpse of the development and current state-of-the-art surgical staples in consideration with research from a commercial point of view. On a special note, this review also describes a very brief outline of the regulatory aspects and some common internationally acceptable ‘de jure standards for the development of commercially viable surgical staples.
More, N., Ranglani, D., Kharche, S., Choppadandi, M., Ghosh, S., Vaidya, S., & Kapusetti, G. (2021). Current challenges in identification of clinical characteristics and detection of COVID-19: A comprehensive review. Measurement: Sensors, 16, 100052. https://doi.org/10.1016/j.measen.2021.100052
Abstract: World Health Organization (WHO) declares the COVID-19 outbreak as a pandemic. The newly emerging infection has caused around one million deaths worldwide and still counting. There is no specific treatment for the disease, and it can only contain by breaking the spread. So that early and rapid diagnosis of the infection is the only way to control the outbreak. The COVID-19 virus affects the human respiratory system and subsequently infects other vital organs. In consideration of the diagnosis, the present review focuses on the critical diagnostic approaches for COVID-19, including RT-PCR, Chest-CT scan, some biosensor-based systems, etc. Moreover, this review is a specific bird's eye view on recent developments on the point of care devices and related technologies. Additionally, it presented a small glimpse of the pathophysiology and structural aspects of COVID-19. Therefore, the current review can motivate and help the reader to develop cutting-edge diagnostic technologies for the early and rapid detection of the COVID-19.
Pulugu, P., Ghosh, S., Rokade, S., Choudhury, K., Arya, N., & Kumar, P. (2021). A perspective on implantable biomedical materials and devices for diagnostic applications. Current Opinion in Biomedical Engineering, 18, 100287. x https://doi.org/10.1016/j.cobme.2021.100287
Abstarct: New sensors, sensing schemes, and sensor materials have revolutionized the field of personalized diagnostics. Functional, biocompatible, and flexible materials have spearheaded the development of various wearable and implantable sensors over the last decade. The present-day sensors may be integrated into the patient's body and monitor the desired physiological parameters in real time. This has been achieved by hybrid biomaterials that exhibit enhanced electrical, mechanical, magnetic, and chemical properties when compared with the conventional biomaterials. These materials are developed through surface modification and doping with nanomaterials, rendering them amenable for any biosensor development. These sensors are also capable of seamlessly transmitting the acquired data to specific recipients using advanced electronics. In this article, we have presented a review of some of the recent advancements in the domains of neural, cardiovascular, metabolic, and musculoskeletal sensor systems, which have seen significant developments in recent times.
Ghosh, S., Shah, D., More, N., Choppadandi, M., Ranglani, D., & Kapusetti, G. (2022). Clinical Validation of the Medical Devices: A General Prospective. In BioSensing, Theranostics, and Medical Devices (pp. 265-297). Springer, Singapore.
Abstract: Over the years, the spectrum of medical devices has been diversified from very simple to the highly complex platform, simultaneously, the risk factors associated with the devices have diverges. So, now to be in no doubt and maintain the performance feasibility and clinical safety issues of any devices throughout the product life cycle, various regulatory organizations of different countries put some clause in the name of “clinical validation,” “clinical investigation,” or “clinical assessment report.” This clinical validation process makes convinced and justifies all the clinical assessment data regarding the devices’ safety, effectiveness, and performance feasibility to the regulatory agency to market the product in a specific market across the globe. The clinical validation procedure and requirements are very specialized and succinct to answer all the queries of the regulatory body depending upon the device class, working principle, and risk associated with it. In recent times, various established regulatory frameworks like USFDA, TGA, and CDSCO make the clinical investigation and validation of the devices mandatory to launch the product into the respective market. The process of clinical confirmatory and validation is a never-ending procedure for high risk associated devices, as per the recent implementation of post marketing clinical follow-up (PMCF), post-market surveillance (PMS), and periodic safety update report (PSUR) by the regulatory authorities of various countries. In the following chapter, we are tried to give a broad impression and a detailed account of prerequisites, procedures, and strategies of various clinical validation plans concerning various regulatory authorities. The goal or intention of the clinical validation process of medical devices is to make assured that the device does not exhibit any surplus effect or events throughout its life cycle, which are questionable or reasons for product fiasco.